Actively Recruiting
Sleep and Stress Study
Led by RDC Clinical Pty Ltd · Updated on 2026-04-23
240
Participants Needed
1
Research Sites
42 weeks
Total Duration
On this page
Sponsors
R
RDC Clinical Pty Ltd
Lead Sponsor
G
Gencor Pacific Limited, Hong Kong
Collaborating Sponsor
AI-Summary
What this Trial Is About
The goal of this clinical trial is to learn if natural supplements (lavender oil, PEA, and OEA) work to improve sleep and reduce stress in adults with moderate stress levels and sleep difficulties. It will also learn about the safety of these natural supplements. The main questions it aims to answer are: * Do these supplements improve sleep quality? * Do they reduce perceived stress levels? * Do they reduce anxiety symptoms? * What medical problems do participants have when taking these supplements? Researchers will compare three active treatment groups (lavender oil, PEA, Trpti which contains OEA) to a placebo (a look-alike capsule that contains no active ingredients) to see if these natural supplements work to improve sleep and reduce stress. Participants will take 1 capsule (either active supplement or placebo) every day for 8 weeks and attend 2 clinic visits with a phone check in in between.
CONDITIONS
Official Title
Sleep and Stress Study
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Generally healthy adults aged 18 and over
- Able to provide informed consent
- Score of at least 14 on the Perceived Stress Scale (PSS)
- Have sleep complaints occurring at least 2 times per week, including difficulty initiating sleep, maintaining sleep, or early-morning awakening causing distress or impairment
- Agree not to use other dietary supplements for sleep, depression, stress, or anxiety besides the study product during the trial
- Agree not to change current diet or exercise habits during the trial
- Agree not to participate in another clinical trial during the study period
You will not qualify if you...
- A WHO-5 Well-Being Index score of 28 or less
- Severe sleep complaints with Insomnia Severity Index greater than 21
- Taking prescribed medication for sleep, depression, or anxiety
- Serious illnesses such as asthma, depression, anxiety disorder, bipolar disorder, insomnia, organic sleep disorders, neurological disorders like MS, kidney, liver, or heart disease
- Unstable illnesses including diabetes and thyroid dysfunction
- Current cancer or cancer treatment within prior 2 years, excluding basal cell carcinoma
- Currently taking anticoagulant medications including Coumadin, Heparin, Dalteparin, Enoxaparin, or low dose aspirin
- Active smoking, nicotine use, or drug abuse
- Chronic or current alcohol use exceeding 21 drinks per week
- Consuming more than 500 mg of caffeine daily
- Pregnant or breastfeeding women
- Allergic to any ingredients in the active or placebo capsules
- Currently or recently (past 1 month) participating in other clinical trials
- Any condition making participation unsuitable in investigator's opinion
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
RDC Clinical
Brisbane, Australia
Actively Recruiting
Research Team
A
Amanda Rao, PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
QUADRUPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
4
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here